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The PET/CT scanner has been recognized as a powerful diagnostic imaging 
modality in oncology and radiation treatment planning.  Traditionally, PET has been used 
for quantitative analysis, and diagnostic interpretations of PET images greatly relied on a 
nuclear medicine physician’s experience and knowledge.  The PET data set represents a 
positron emitter’s activity concentration as a gray scale in each pixel.  The assurance of 
the quantitative accuracy of the PET data is critical for diagnosis and staging of disease 
and evaluation of treatment.  The standard uptake value (SUV) is a widely employed 
parameter in clinical settings to distinguish malignant lesions from others.  SUV is a 
rough normalization of radioactive tracer uptake where normal tissue uptake is unity.  
The PET scanner is a sensitive diagnostic method to detect small lesions such as lymph 
node metastasis less than 1 cm in diameter, whereas the CT scanner may be limited in 
detecting these lesions.  The accuracy of quantitation of small lesions is critical for 
predicting prognosis or planning a treatment of the patient.  PET/CT uses attenuation 
correction factors obtained from CT scanner data sets.  Non-biological materials such as 
metals and contrast agents are recognized as a factor that leads to a wrong scaling factor 
in the PET image.  We challenge the accuracy of the quantitative method that physicians 
routinely use as a parameter to distinguish malignant lesions from others under clinical 
settings in commercially available CT/PET scanners.  First, we verified if we could 
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recover constant activity concentration throughout the field of view for small identical 
activity concentration sources.  Second, we tested how much the CT-based attenuation 
correction factor could be influenced by contrast agents.  Third, we tested how much 
error in quantitation could be introduced by object size.   
Our data suggest that the routine normalization process of the PET scanner does 
not guarantee an accurate quantitation of discrete uniform activity sources in the PET/CT 
scanner.  Also, activity concentrations greatly rely on an object’s dimensions and object 
size.  A recovery correction factor is necessary on these quantitative data for oncological 
evaluation to assure accurate interpretation of the activity concentration.  Development of 
parameters for quantitation other than SUV may overcome SUV’s inherent limitations 
reflecting patient-specific physiology and the imaging characteristics of individual 



















The hybrid system of a PET scanner combined with CT scanner (PET/CT) has 
gained popularity in the oncological community since its commercial introduction to the 
market in early 2001 [1].  The integrated PET/CT unit superimposes PET images on CT 
images with minimum co-registration problems between the two images by minimizing 
patient movement.  Simultaneously providing anatomical information by CT scan helps 
physicians to identify the anatomical location of the lesion demonstrated on the PET 
images [2].  Integrated PET-CT has been shown to improve accuracy of the staging in 
cancers, such as lung cancer [3, 4] and head and neck cancer [5].   Another uniqueness of 
the PET/CT scanner is that the CT numbers gained from the CT data sets are converted 
into attenuation correction factors to correct images in the PET data sets.   
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Traditionally PET has been employed to differentiate benign lesions from 
malignant lesions and for staging of malignancy as a diagnostic modality [6-8].  
Currently, the advantage of the PET/CT in radiation treatment planning (RTP) has been 
recognized because of its ability to demonstrate a tumor’s physiological information.  In 
RTP the target volumes are contoured and a dose is prescribed to these lesions.  The 
PET/CT information potentially changes tumor target volume in the treatment planning 
[9].  Therefore, the quantitative accuracy of the PET/CT scanner is an issue.  
 2-deoxy-2-[18F]-fluoro-D-glucose (18F-FDG) PET/CT has been used as a 
radioactive tracer for imaging of brain, heart, and tumor diagnosis.  18F-FDG is an analog 
of glucose (Figure 1-1).  This tracer is injected into a patient intravenously and is 
transported into the cells mainly by the glucose transporters, GLUT1 and GLUT4 and 
phosphorylated by hexokinase, a rate limiting enzyme of glucose metabolism (Figure 1-
2).  18F-FDG-6-P, a phosporylated 18F-FDG metabolite is negatively charged and cannot 
leave the cell, where it accumulates. With PET, we can visualize 18F-FDG-6-P trapped 
into the cells of various tissues [10]. Cancer cells have a higher glycolysis rate compared 
to the tissue in which it arose. Increased 18F-FDG uptake of the hypoxic cell reflects that 
these cells require more glucose uptake to support anaerobic glycolysis, mediated by an 
increase in expression of glucose transporters in the cell membrane. 18F-FDG uptake does 
not directly reflect tumor-specific glucose metabolism.18F-FDG uptake can occur in other 
glucose utilizing cells such as macrophages and leukocytes that are rich in inflammatory 
tissue and may cause a false positive study in PET.  A recent histopathological study of 
18F-FDG uptake showed that 18F-FDG is selectively demonstrated within viable and 
hypoxic cells in vivo [11].  This study indicates that PET has a potential to distinguish 
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hypoxic cell groups, which are more resistant to radiation therapy and more likely to be a 
source of distant metastasis or recurrence in the future. This suggests a unique role for 
PET in oncology treatment planning by distinguishing more resistant cell groups from the 
others; using PET for targeting with narrow beam intensity modulated radiation therapy 
can potentially deliver higher dose selectively to the more radiation resistant volume.  
Imaging with 18F-FDG is not the only radiopharmaceutical in the application of 
PET in oncology.  3’-deoxy-3’-[18F] fluorothymidine (FLT) assesses tumor proliferation.  
FLT is uptaken by cells and phosphorylated by thymidine kinase 1.  Images of FLT-
monophosphate trapped in the cell reflect the thymidine kinase activity, which also is a 
measure of the rate of tumor proliferation.  Knowledge of the patient’s specific tumor 
proliferation potentially changes the fractionation schedule of radiation therapy [9]. 
 One of the widely used quantitative parameter to distinguish malignant from 






mLMBquptakeTracerSUV .     (1) 
The tracer does not distribute evenly throughout an entire patient’s body.  Normal SUV is 
by definition under this model roughly equal to one.  Malignant lesions have higher 
glucose metabolic rates compared to the normal tissue with SUV’s usually ranging from 
4 to 15 [12].  A region of interest (ROI) is drawn by a physician and maximum, minimum, 
and average SUV are displayed on the image according to the software setting of the 
scanner.  The maximum SUV particularly has diagnostic value, because (1) its value is 
independent of the lesion’s area drawn by a person and (2) tumor lesions have 
heterogeneous SUV values, therefore we are most concerned with the highest metabolic 
rate.   
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 Our question is: “How reliable are these SUV values?”  PET scan images use gray 
scale maps to depict activity concentrations of a positron emitting source in the body. We 
decided to investigate major factors that can adversely alter SUV.  The normalization 
process to an individual patient in Equation 1, where one divides by uniform distribution 
of the normal tissue, causes more error.  Each individual has different metabolism of the 
tracer.  Distributions of the activity concentration reflect an individual’s physiological 
function.  Therefore, we ignored the denominator of Equation 1 and only concentrated on 
activity concentrations (the numerator) that are utilized to calculate SUV.   
 Many factors affect quantitative accuracy of the PET/CT; some are particularly 
unique to hybrid PET/CT scanners [1, 13, 14].  The scaling problem of attenuation values 
(µ) at 70 keV into 511 keV is an inherent problem for the PET/CT unit.  The µ is an 
energy-dependent value.  The attenuation correction factors are obtained from a CT scan 
at a mean energy of 70 keV and scaled into a µ at 511 keV by a manufacturer-dependent 
algorithm [1].   
One problem is oral and intravenous iodinated contrast materials are commonly 
used in CT.  They enhance attenuation in the gastrointestinal tract and in vessels to assist 
visual discrimination of these anatomic structures.  This contrast can create artifacts in 
both the CT image and CT-based attenuation correction of the PET image [15-17].  
Partial volume effect is another factor that affects quantitative analysis in PET.  
The volume of the object, relative to the spatial resolution of the imaging system, affects 
the recovery of activity concentration of PET and single photon emission computed 
tomography (SPECT).  This effect has been discussed extensively for PET and SPECT 
brain research studies [18].   It is critical in a malignancy, such as glioblastoma 
 4
maltiforme, where a physician is interested in whether recurrent tumor is present 
compared to the normal cortex.   We noticed that this partial volume effect of the 
PET/CT scanner is not widely considered when it comes to image interpretation in 
oncology settings.   
Another issue that we did not cover in this thesis is organ movement. 
Physiological activity such as respiration, heart beat, and bowel movement are 
problematic [13, 19, 20]. Sometimes anatomical location of the lesion is disregarded 
because of artifacts created by physiological motion.  Diagnosis of the patient with 
lesions at the base of the lung and the dome of the liver is particularly difficult.  To solve 
respiratory motion, respiratory-gated PET scanning is under research development [21, 
22].  
Physicians are advised to review two sets of fused PET/CT images, using both 
attenuation corrected PET and non-attenuation corrected PET images [13].  One of the 
issues that PET/CT is facing is that this diagnostic area lies at the interaction of nuclear 
medicine physicians, radiologists, and radiation oncologists.  Well-trained nuclear 
medicine physicians can make reasonable judgments whether a lesion is malignant or not 
from these two sets of data.  However, most manufacturers do not routinely fuse non-
attenuation corrected PET images to CT image data sets.    
A goal is to use PET/CT scanners as a method of quantitative evaluation 
reflecting the biological behavior of the tumor.  The accuracy of these quantitative values 
is critical to the target.  A decision made about a patient’s treatment causes tremendous 
effects on his or her quality of life.  We were very curious in the clinical setting if the 
default PET/CT image reconstructions were sufficient to overcome attenuation correction 
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artifacts mentioned above and also the partial volume effects.  Further, we search to 
understand the limitations of PET/CT in the clinical settings. 
1.2 Organization of the Thesis 
Chapter 2 describes basics of PET/CT physics and instrumentation to understand 
the performance of the scanners. Chapter 3 describes the performance of the PET/CT 
scanner we tested including counting-rate characteristics and uniformity of response. 
Chapter 4 discusses the effect of contrast agents on attenuation-correction accuracy.  
Chapter 5 describes an investigation of partial volume effects and possible methods to 
recover activity concentrations.  The final chapter provides a summary of the work and a 



























Figure 1-2:  18F-FDG metabolism and intracellular accumulation. Adopted from Thrall 






























2.1 Instrumentation and Physics of PET/CT 
Scanner 
 
2.1.1 Positron Decay 
Many proton rich radionuclides decay via positron emission into a more stable 
state.  A proton is converted into a neutron, a neutrino, and a positron.  
1p+  →    0n + 1β+ + ν                       (2) 
 ZX    →    Z-1Y + 1β+ + ν 
A positron is the anti-matter of an electron. The positron emitted from the nucleus will 
lose kinetic energy by interactions with the surrounding matter. The path is deflected 
from its original path by any of four types of interactions: inelastic collisions with atomic 
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electrons, elastic scattering with atomic electrons, inelastic scattering with a nucleus, or 
elastic scattering with a nucleus.  The positron takes a torturous passage through matter, 
which complicates the estimation of range.  Eventually, the positron and an electron may 
form a metastable intermediate species, positronium.  The electron and positron revolve 
around their center of mass; positronium’s half-life is about 10-7 seconds. The 
positronium formation occurs in about one-third of cases in water or human tissue while 
direct annihilation occurs the rest of the time [23]. 
When the positron and electron annihilate, they give off electromagnetic radiation.    
The most probable mode is rest mass converted into two photons of 511 keV each, 
propagating at 180 degrees to conserve momentum when the positronium has no residual 
kinetic energy (Figure 2-1). This principle is used to determine the line of response in the 
PET scanner.  At less than 1% probability, three photons can be emitted.  Also, not all 
annihilation events are zero-momentum; to safisfy momentum-conservation, these photon 
pairs are not exactly emitted at 180 degrees (a maximum deviation of ±0.25 degrees) 
[24].  In water, about 65% of annihilations deviate from co-linearity.  This effect 
contributes resolution blurring of 1.5 mm to 2.0 mm for 80 cm to 90 cm diameter PET 
rings [23, 24].  
There are several nuclides used in PET:  11C (T1/2: 20.3 min, max range in water: 
5.4 mm) 13N (9.97 min, 5.4 mm)), 15O (124 sec, 8.2 mm), and 18F (110 min, 2.4 mm). 
18F-FDG is the predominantly used radionuclide for PET imaging because of its 

























Figure 2-1:  Illustration of positron decay and annihilation photons.  The positron takes a 
torturous passage through matter and interacts with an electron. A metastable species, 
positronium, is formed about one-third of the time in water.  Upon annihilation, the rest 
mass is usually converted into two photons of 511 keV at 180 ± 0.25 degrees. 
 
2.1.2 Photon Interaction in Matter 
Among photon interactions -- coherent scattering, photoelectric effect, Compton 
scattering, and pair production -- photoelectric effect and Compton scattering are 
particularly important in PET imaging physics.  For soft-tissue and bone, the total 
attenuation coefficients are dominated by photoelectric absorption in the photon energy 
range below 100 keV and dominated by Compton scattering in the photon range of 200-
1000 keV [25].   
• Photoelectric effect 
Photoelectric effect dominates in human tissue at energies less than 100 keV.  The 
fact is important for PET/CT scans that use CT data for attenuation correction.  Mean CT 








µ                                        (3) 
for photon energies from 10 keV to 500 keV and atomic numbers from 1 to 92. 
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• Compton Scattering  
Compton scattering is directly proportional to Z and inversely dependent on 
photon energy from 10 – 1000 keV.   Monte Carlo simulation of the interaction of 
annihilation photons with tissue-equivalent material in PET shows that more than 80 
percent of scattered events that are detected have undergone only a single scattering 
interaction [23]. 
 
2.1.3 Photon Spectrum 
PET images are based on detecting monoenergetic photons (511 keV) produced 
by annihilations.  X-ray tubes produce a continuous bremsstrahlung spectrum which also 
contains characteristic X-rays with discrete energies corresponding to the transitions of 



















Figure 2-2:  Photon energy spectral distribution for x-ray source and positron source [25].   
 
Low energy photons are absorbed in matter by photoelectric absorption, shifting 
the average spectral energy to the right.  This beam hardening effect causes significantly 
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undesirable effects on X-ray imaging because it introduces image contrast variations 
depending on the photon paths in addition to the object attenuation properties. 
An X-ray CT detector operates in charge-integration mode and does not have 
energy discrimination, unlike a nuclear medicine detector.  PET detectors operate in 
single-photon counting mode and have energy discrimination, ideally allowing rejection 
of scattered photon counts. 
2.1.4 True, Random and Scattered Events 
• True and Random Events 
To be considered a valid event, the PET scanner must detect two 511 keV events 
simultaneously in two different detectors (Figure 2-3). The system assigns a line of 
response (LOR) for coincidence events, a straight line connecting the two detectors. 

















*       Annihilation event
Annihilation photon
Assigned LOR
Figure 2-3:  True, scattered, and random events 
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The difference in time window (Figure 2-4) is set under consideration of the 
following factors: time of travel of two annihilation photons, the detector’s scintillation 
time, and the electronics’ processing time. The scintillation time affects the time 
resolution, which is the uncertainty in the timing characteristics due to fluctuation of 
scintillation decay.  A detector with short scintillation time constant has a small timing 
resolution.  The maximum difference for time of travel by each photon before interaction 
in the detectors is about 3.33 ns using speed of light (3x108 m/s) and for a 1 meter scanner 
diameter.  At time T, if detector 1 produces a signal, then any signal produced by detector 
2 between T+τc and T-τc is considered a coincident event. The resolving time of the 
circuit is the coincidence time window and expressed as 2 τc.   
Random events occur when photons from different annihilations reach the 
detector within the coincidence time window.  If S1 and S2 are singles count rates on 
channel 1 and 2 (counts/second), the random (R) events can be expressed as follows. 
2112 2 SSR c ⋅⋅⋅= τ                                     (4) 
For example, for a typical bismuth germanate Bi4Ge3O12(BGO) scanner, the coincidence 






















Figure 2-4:  Illustration of the coincidence true window.  Signal B is in coincidence with 
signal A if it occurs any time within the coincidence time window. 
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From this equation, the total random rate is approximately proportional to the 
square of total count rate for all detector pairs.  To minimize random coincidences, one 
can decrease the coincidence window; however this introduces statistical error due to 
event triggering fluctuation. The use of fast scintillators [decay constant - GSO: 60 nsec, 
lutetium oxyorthosilicate doped with cerium Lu2SiO5 (LSO): 40 nsec] can reduce the 
time window.  However, it can not be reduced more than the time-of-flight (3-4 nsec) that 
is set by the scanner diameter.  The optimal window is typically set to 3-4 times the full 
width at half maximum (FWHM) timing resolution of the PET scanner.   The typical 
coincidence time window is 12 ns for BGO-based systems and 8 ns for GSO and NaI(Tl)-
based systems.  
All coincidence events are called prompt events and are expressed as 
Prompts (P) = trues (T) + scatters (S) + randoms (R) 
RSPT −−=                          (5) 
By using this formula (4) and (5) with known S1 and S2, random events can be removed 
statistically from prompts.  However, randoms correction process results in propagation 
of noise in the data set; therefore the best solution is to reduce random events either by 
reducing the count rate or by using a smaller coincidence time window. This is the reason 
why a PET scanner with good timing resolution is desirable. 
• Scattered Events and Energy Windows 
A certain portion of photons created in the body will interact in the body either by 
photoelectric absorption or Compton scattering.  A Compton-scattered photon propagates 
in  a different direction than the original unscattered photon.  Coincidence events due to 
scattered photons cause misinterpreting of LORs and misrepresenting the true activity 
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distribution within the image (Figure 2-3).  This causes blurring in the image, therefore it 
is important to remove these events.  
Scatter is an especially important component of the signal in 3D imaging 
compared to 2D imaging where scatter contributes only a minor part of the signal [26].  


















−∝                                     (6) 
AC:         attenuation correction factor (See Chapter 3) 
DT:         dead time correction   
ηtrue:        normalization coefficient for scattered coincidence 
ηscatter:     normalization coefficient for true coincidence 
scatteredS : scattered count rate 
There are several efforts to approximate these normalization coefficients. Unfortunately, 
the scatter normalization coefficient is not a unique value (it depends on scattering angle).  
However, variation in scatter normalization coefficients is probably negligible compared 
to the scatter estimate itself.   
Ideally, we should set the energy window exactly at 511 keV to reject all 
scattering events.  This cannot be done for real PET scanners: scintillation crystals have a 
limited energy resolution; setting the energy window too wide will accept too much 
scatter, degrading image quality.  If we set the energy window too narrow, it will reject 
some true events.   Commercial PET scanners use wide energy windows to achieve high 
sensitivity, at the expense of accepting some scattered events.  NaI(Tl) based scanners 
have good energy resolution (10–15%) and the energy window is set from 435 keV to 
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590-665 keV.  BGO crystals have worse energy resolution compared to NaI(Tl) crystals.  
A typical BGO scanner’s energy window is set from 300-350 keV to 650 keV. [24].  
One of the methods to reduce scattering events is use of lead or tungsten septa (i.e. 
2D mode).  In multi-ring scanners, septa reduce scattered photons reaching the detectors.  
Septa also reduce the sensitivity of the scanner.  Another method is to mathematically 
correct scattering events by using object-scatter models; however, scatter is very object-
dependent. Currently, simple but computationally efficient models are used, but these are 
inherently limited in their accuracy.  Monte Carlo methods can provide more realistic 
models but are too computationally intensive for clinical practice; recent developments of 
acceleration techniques eventually may make Monte Carlo methods feasible for clinical 
practice [27]. 
2.1.5 Sensitivity and Depth of Interaction 
The sensitivity of a PET scanner is determined by its geometry and detector 
stopping power.  The ideal geometry of PET scanners is (1) a small diameter and large 
axial field of view (FOV), and (2) a scintillation detector with high stopping power and 
high energy resolution.  After a photon enters the detector, it travels a short distance 
before depositing its energy.  Typically, the event registers the LOR as a connection of 
two points on the entrance surfaces of the detectors rather than the two actual interaction 
points.  The error from this assumption becomes large when the photons enter at an 
oblique angle and with thick detectors.  This parallax error is worst when annihilation 
occurs in the periphery of the scanner’s FOV.  The thickness of the detector trades off 
sensitivity and stopping power with parallax error.  Detectors providing depth-of-
interaction measurement are under research, e.g. [28].   
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2.2 Photon Attenuation and Attenuation 
Correction Factors 
 
2.2.1 Attenuation Correction Factors 
Suppose the scanned body consists of a homogeneous material, and d1 and d2 are 
the distance each annihilation photon traveled through the tissue (Figure 2-5).  Then the 
probability of uncollided photons emitted along line D escaping from an object is given 
by 
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( )DNDlinealongobjectthefromemittedphotonsUncollided ⋅−⋅= µexp0  




Figure 2-5:  Attenuation correction factor in homogeneous material 
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If the attenuation coefficients along the LOR are not uniform (Figure 2-6), then the 
relation becomes 
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Figure 2-6: Attenuation correction factor in heterogeneous material. 
 















0 exp µ                                (9) 
 
The factors to correct non-uniform attenuation correction coefficients are called 
attenuation correction factors (ACFs) and they are obtained from transmission scans.  
Widely-used attenuation correction factors are obtained using (1) positron sources, (2) 
gamma-ray sources, and (3) x-ray sources (Table 2-1).  If we use an emission source 
other than a positron emitter, we must re-scale the attenuation correction factors since the 
attenuation coefficients are energy dependent.  There are three methods for emission 
scans: (1) positron sources: 68Ge/ 68Ga [β+ emitter (511 keV annihilation photon), 
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transmission data from coincidence events]; (2) γ-ray Sources: 137Cs [a γ emitter (662 
keV) and single events are collected as a transmission scan.  The attenuation correction 
factors obtained are at 662 keV, not at 511 keV, and require scaling down.  Both scaling 
and segmentation methods were used for this correction]; (3) CT sources, which describe 
next.   
• CT Sources 
There are four advantages of using CT scan for transmission scans:  (1) lower 
statistical noise compared to the radionuclide sources, (2) faster acquisitions, (3) no 
contamination from emission photons, (4) it does not require periodic replacement of 
positron sources, and (5) CT with PET can be used to localize activity in relation to 
anatomy.  The disadvantage of using CT scan for ACFs is that it requires re-calculation 
of ACFs at 511 keV from attenuation coefficients obtained from 30-140 keV spectrums 
by CT scans.  There are three conversion methods:  segmentation, scaling, and dual-
energy CT scans. 
 
Table 2-1:  Comparison of the transmission methods for PET [25].   
 
Sources positron single gamma X-ray
Photon energy (keV) 511 662 for Cs-137 continuous:~30 to 140
Patient scan time (min) 15 - 30 ~ 5 - 10 ~ 1
Transmission noise highest high insignificant
Potential for bias/artifacts low some highest  
 
• Segmentation  
Segmentation classifies CT images into different tissue types (such as soft tissue, 
lung, and bone).  Then CT values are changed to corresponding attenuation coefficients 
at 511 keV.  A problem arises when the tissue changes value continuously (in the lungs, 
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up to 30%); replacing by a single attenuation coefficient at 511 keV potentially 
introduces an error [25].  
• Scaling 
The images created by CT are approximately linearly correlated to the attenuation 
coefficients of soft tissue.  CT values multiplied by the ratio of the attenuation 
coefficients at 511 keV and at mean CT energy are called scaling [1, 25].  For low-Z 
material, the approximation of the attenuation coefficient is accurate when multiplied by 
scaling factors.  However, different scaling factors are necessary for bones, because 
linear scaling is a poor approximation.  This is because the high Z value of calcium 
(Z=20) leads to higher photoelectric attenuation coefficients at CT energies.    
Another method, called the “hybrid method” is a combination of scaling and 
segmentation (Figure 2-7).  This separates bone and non-bone components and then uses 
separate scaling factors for each component. There is a discontinuity at 300 HU.  The 
“bilinear method” is piece-wise continuous [25].  Although both the hybrid and bilinear 
methods give reasonable approximations for biological materials, in the presence of 
contrast materials and metal objects, the approximations are still inaccurate.   
• Dual Energy X-ray Imaging 
By scanning two or more spectra of an x-ray beam, CT numbers can be converted 
into 511 keV linear attenuation coefficients as a weighted sum of photoelectric absorption 
and Compton scattering.  The problem of this method is errors caused by image noise.  
CT scan is not the only-method to map attenuation coefficients throughout the 
body.  For instance, T1-weighted magnetic resonance imaging (MRI)  has been 
investigated for attenuation and scatter correction in 3D brain PET imaging [29].   
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Figure 2-7:  Conversion of CT numbers to linear attenuation coefficients at 511 keV.  The 
hybrid method has a discontinuity at 300 HU and the bilinear method has a change in 
slope at 0 HU [25].   
2.2.2 Problems for CT-based Attenuation 
Correction 
A mismatch of calculated and true attenuation coefficients introduces biases and 
artifacts in the reconstructed PET images.   
• Spatial Mismatch 
CT scans are usually obtained at end-inspiratory phase as opposed to PET scans, 
which are obtained as respiratory-averaged images.  This causes spatial mismatches.  One 
of the solutions is to acquire CT images during the partial expiratory phase to match with 
the PET emission images under the sacrifice of diagnostic quality of CT images.  
Respiratory gating and motion tracking devices are under investigations [21, 22].  
• Truncation Artifacts 
PET scanners often have larger FOV (50-70 cm) than a CT scanner’s FOV (45-60 
cm).  PET scans are often obtained with the patient’s arms next to the body while the 
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arms may be raised during the CT scan.  For a large patient, some part of the body may 
be outside the CT’s FOV, resulting in some bias of the reconstructed activity distribution 
due to erroneous ACFs  [13].   
• Metal Implant 
Many oncological patients have metal implants such as chemotherapy ports, 
pacemakers, dental fillings, and artificial joints. These high-Z materials cause significant 
artifacts in the attenuation correction factor obtained in the CT energy range.  It is 
especially important to reconstruct attenuation uncorrected images in these patients.     
• Contrast Agents 
Intravenous (IV) contrast agents are composed of iodine (Z=53) at concentrations 
of 300-380 mg/mL.  Typically, 100-200 mL of IV contrast agent is injected as a bolus at 
a rate of 1.5 to 5 mL/s [25].  The distribution of contrast agent depends on the time after 
injection.  Over time, the agent is excreted through the kidneys, ureters, and bladder.  
Oral contrast agents are either barium (Z = 56) based or iodine based.  Because of 
increased attenuation due to high Z, these contrast agents produce contrast in a CT image.   
Immediately after a bolus injection, the CT numbers of highly vascularized tissue 
increase to 200-300 from 30-60.  At 511 keV the mass attenuation coefficient of iodine is 
about the same as water or soft tissue (Figure 2.8). Therefore, any scale factor that 
correctly predicts the attenuation factor at 511 keV for bone or soft tissue will 
overestimate the attenuation at 511 keV for contrast agents [25].  According to recent 
literature, intravenous contrast at normal concentrations has little effect on the CT-based 
ACFs, but for oral contrast, larger intestinal volumes and a wide range of concentration 
(about 170 HU in the stomach, about 700 HU in lower gastrointestinal tract where water 
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is absorbed) can potentially cause overestimation of ACFs [1].  A recently-proposed 
approach to avoid over-estimation of ACFs is, for pelvic gastrointestinal oral contrast 




Figure 2-8:  Comparison of scaling of attenuation coefficients.  (a) The mass attenuation 
coefficient is significantly enhanced at CT photon energies for iodine, but at 511 keV it is 
similar to other materials.  (b) Comparison of the linear attenuation coefficient at 511 
keV vs. CT numbers predicted with the true value for iodine. [25]  
 
2.3 Image Reconstruction Algorithms 
2.3.1 Overview of Reconstruction Algorithm 
PET data is acquired in either 2D or 3D mode.  The 3D mode requires more 
memory and more computational time.  Filtered-backprojection algorithm (FBP) is a 
classical analytical reconstruction algorithm widely used for computed tomography.  In 
contrast to analytical algorithms, iterative algorithms assume a statistical distribution of 
the data is derived from a Poisson model.  Recent developments of fast iterative 
algorithms allow more accurate reconstruction of acquired data.  The ordered subset 
expectation maximization (OSEM) algorithm in 2D mode is widely used in commercial 
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PET/CT scanners.  3D iterative reconstruction is independent of geometry, but it is 
computationally intensive.  Hybrid algorithms combine efficient 2D iterative algorithms 
with a fast rebinning algorithm, where 3D data is reduced into 2D data.   
2.3.2 2D Data 
• Analytic 2D Reconstruction 
 The Radon transform of an object ( )yxf , , denoted as ( )φ,sg , is defined as its 
line integral along a line inclined at an angle φ  from the y-axis and at distance s from the 
origin. 
Mathematically, it is written as 





−+=ℜ≡ dxdysyxyxfyxfsg )sincos(,,, φφδφ    (10) 
where ℜ  is the Radon transform operator. 
In medical imaging, we are interested in recovering ( )yxf ,  from the sinogram ( )φ,sg , 
which is the measured PET data, after corrections for scatter, randoms, and attenuation. 
Associated with the Radon transform the back-projection operator is defined as 
                         (11) ( ) ( ) ( ) φφφφθ π dyxgsgyxb ∫ +=Β≡ 0 ,sincos,,
The reconstructed image 
                                                                 (12) ( ) fBBgyxf ℜ=≡,~








During reconstruction, filtering or deconvolution is used to remove the PSF blurring, 
recovering the original object f(x, y).  Details of the FBP reconstruction methods can be 
found in imaging textbooks [30, 31]. 
• Iterative Reconstruction 
Filtered backprojection is computationally efficient.  It is based on the assumption 
that the projection images are perfect projections of a three dimensional object.  This is 
not true: Compton scattering, and photon attenuation factors in the patient affect the 
LORs.   Iterative reconstruction has been developed to overcome this problem. An initial 
activity distribution in the patient is assumed, and then projection images are calculated 
from the assumed activity distribution.  The calculated projection images are compared 
with the actual images and the assumed activity distribution is modified and recalculated 
[32].   
 The most widely used iterative algorithms in PET are the maximum-likelihood 
expectation maximization (ML-EM) algorithm and its accelerated version OSEM.  
OSEM was proposed in 1994 and is sufficiently fast for clinical applications.  With each 
iteration, the target function is updated several times, proportionally accelerating 
convergence. An optimization of subsets and iterations is required when the method is 
applied to real noisy data. The detail of the algorithm is explained elsewhere [23, 24].  
• 3D Analytical Reconstruction by Rebinning 
Reconstruction of 3D PET data requires large amounts of memory due to the 
large number of LORs.  Strictly, 2D mode produces N sinograms. In practice, in a multi-
ring system, we allow cross-slices and having 2N-1 detector rings.  A full 3D mode 
produces N direct transaxial slices and N (N-1) oblique sinograms (N2 in total).  
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Rebinning is a method to estimate 2D transaxial sinograms from oblique sinograms 
acquired in 3D mode.  Two rebinning approaches are commonly used: single-slice 
rebinning (SSRB) and Fourier rebinning (FORE) [23].  SSRB assumes that each 
measured oblique LOR only traverses a single transaxial section within the support of the 
tracer distribution and average overall available estimates.  SSRB induces axial blurring 
and transaxial distortions because of its approximations.  FORE is more accurate than 
SSRB. Fourier transforms and normalization are used to rebin the data according to septal 
frequency information   After inverse 2D Fourier transform, the rebinned transaxial slices 
are obtained.  This algorithm assumes that the data are line integrals of the tracer 
distribution and each oblique sinogram is sampled fully.  FORE is sufficiently accurate in 



















Uniformity of Activity Concentration of 
Discontinuous Positron Emitting Sources 
 
 
3.1 Instrumentation of PET/CT Scanners 
3.1.1 True, Scatter, and Random Events and Energy 
Window 
 
In a clinical PET/CT exam, approximately 10 mCi 18F-FDG is injected 
intravenously into the patient.  It is important to understand how the physical 
performance of the PET/CT scanners produces the observed image quality.  To assess the 
performance of the CTI-Siemens PET scanner, we recorded true, scattered, and random 
coincidence events for different activity levels.  Energy windows are set by the 
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manufacturer and we do not have equipment to test the energy window width directly in 
our facility.   
3.1.2 Materials and Methods 
Data in this study was acquired with a CTI-Siemens Reveal-HD (Knoxville, TN).  The 
acquisition and reconstruction protocols use the following manufacturer’s settings (Table 
3-1). 
 
Table 3-1:  Acquisition and reconstruction parameters of CTI-Siemens Reveal-HD.   
F-18 half-life (sec) 6586.2
Sinogram dimensions 3
            matrix size [1] 228
            matrix size [2] 228
            matrix size [3] 239
Scale factor (mm/pixel) [1] 2.25
Scale factor (mm/pixel) [2] 1
Scale factor (mm/pixel) [3] 2.425
Holizontal bed translation stepped
Axial compression 9
Maximum ring difference 22
Number of segment 5
Total number of sinogram 239
Lower energy window (keV) 350
Upper energy window (keV) 650
Number of rings 32
Axial FOV (cm) 15
TransverseFOV (cm) 66
Scintilation Cristals BGO
Number of PMTs 576
Total number of block bucket 96
Number of image planes 47  
 
A 18F-FDG source was drawn into 5mL syringes and the activity was measured with a 
well counter (CRC-15R, Capintec, Inc., Ramsey, NJ).  Each syringe was placed at the 
center of a cylindrical acrylic phantom with 20 cm diameter.  The center of the phantom 
was aligned to the center of the FOV using the PET/CT scanner’s laser indicator.  For 
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each source, true, scatter, and random events were recorded.   Emission data were 
scanned using default settings for a thoracic scan (Thorax C-A-P + C) with one PET bed 
and a 5-minute acquisition time.  Images were reconstructed with OSEM4i8s (4 iterations 
8 subsets) with 128x128 matrix and FORE 3D sinogram rebinning.  ACFs were obtained 
from helical CT scan data with parameters of 120 kVp, 80 mA, 0.8 s per CT rotation, 3 s 
delay, 83 sec scan time. 
3.1.3 Results and Discussions 
For 18F-FDG, our scanner demonstrated a linear relation between activity 
concentration and singles counts for activity less than 10 mCi (Figure 3-1).  True counts 
(coincidence events) were saturated approximately at 2 mCi with 1.7 x 106 counts/second 
(cps).   
In the clinical patient setting, the recommended dose for a 70 kg adult patient is 5-
10 mCi.  The typical dose given to an adult patient for a whole body PET scan is 10 mCi. 
A patient fasts for 4-6 hours prior to the injection.  After injection, the patient rests for 
45-60 minutes; before the PET/CT scan, the patient is asked to void the bladder. The 
amount of 18F-FDG in the bladder depends on many factors including the patient’s renal 
function.  In the literature it is documented that approximately 20% of 18F-FDG is 
discovered in the urine at 2 hours after the injection [33].  FDG’s half life is 110 minutes.  















602lnexpmin)60( 0AA                                                (13)  
If A0 = 10 mCi, then after A(60 min) = 6.85 mCi. 
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Approximately 20% of 18F-FDG appears in the bladder.  The remaining activity in 
the body is about 6 mCi at the time of scanning.  Typical whole body PET uses 6 bed 
positions.  Ignoring the lower body, the rest of the body is about 4 PET beds.  Then 
neglecting the scattering from outside of FOV, approximately 1.5 mCi of activity is 
located in one PET bed.  Comparing to Figure 3-1, a 10 mCi dose is likely to be under 
saturation of the PET scanner’s true counts.   
 As described in the instrumentation section, BGO crystals have good stopping 
power, but poorer light yield and resolution than NaI(Tl) crystals.  BGO crystal’s energy 
resolution is 25%; LLD is set to 350 keV; and ULD is set to 650 keV.  A 3D PET scanner 
does not have septa between the BGO crystals.  A 3D mode acquisition improves 
statistics by increasing the number of counts, but at the expense of increased scattered 
and random events. 
Accepting more counts has an advantage for patients by reducing tracer activity 
and reducing acquisition time. However, 3D mode image reconstruction is 
computationally intensive.  Furthermore, the 3D mode suffers from blurring of images by 
accepting more scattering events as true counts.  This problem is not only from inside of 
FOV but also from outside of the FOV.  This may cause problems in image quality: 
organs located outside of FOV with high 18F-FDG concentration such as brain or bladder 





































































Figure 3-1:  Relation between the activity (in 5mL syringe) at the center of the field of 
view and the measured true, random, and single counts.  The source was 18F-FDG. 
 
 31
3.2 Uniformity of the Radioactivity Concentration 
 
3.2.1 Normalization and Uniform Activity 
Concentration source 
 
In PET instrumentation the best resolution is achieved at the center of the FOV.  
In the ideal system, resolution and sensitivity are constant through out the FOV.  It is well 
known that lines of response (LOR) in a real PET scanner have different sensitivity for 
many reasons, such as solid angle subtended (Figure 3-2), intrinsic variation in detector 
efficiency (e.g., variation in detector gain), detector penetration, septal absorption, 
detector packing fraction , and event timing errors [23, 34]. Therefore, normalization 
coefficients are applied to each LOR to minimize these factors.  The direct normalization 
method uses uniform activity cylindrical 68Ge volume source to measure the 
normalization coefficients.  Ideally, normalization removes sensitivity variations from the 









Figure 3-2:  Illustration of solid angle effects. 
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The normalization method assumes that the normalization coefficients are 
applicable to discrete sources, such as one finds for lesions in the clinical setting.  This is 
a critical assumption for accurate quantitative analysis.  We scanned a 1 mL uniform 
source over the FOV as a pilot study.  The source was composed of 18F-FDG in a micro 
centrifuge tubes.  The result was surprising: recovered activity concentration varied with 
location in the x-z plane (Figure 3-3). The recovered activity concentration varied by 
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Figure 3-3: Variation of the measured activity concentrations as a function of location in 
the FOV.  The micro-centrifuge tube was scanned over a 6 x 4 grid. The maximum 
activity concentration at each location was recorded. The table reports the activity 
concentrations and the surface plot displays the results graphically.  
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3.2.2 Materials and Method 
 
Twenty-one micro-centrifuge tubes (inner diameter 9 mm; height 35 mm) were 
arranged in a Styrofoam disk (diameter 20 cm, thickness 2.5 cm) as shown in Figure 3-4.   
Each tube was arranged in a grid and separated by 4 cm.  18F-FDG was prepared at the 
concentration of 0.2 µCi/mL in a 50 mL volume, mixed well, and each tube was filled 
completely with 1.7 mL of solution.  The center of the disk was aligned to the center of 
the FOV; the disk was scanned in the following orientations: X-Y (transverse), Y-Z 











Figure 3-4:  Arrangement of the micro-centrifuge tubes. Twenty-one micro-centrifuge 
tubes (inner diameter 9 mm; height: 35 mm) were placed in a Styrofoam disk (diameter 
20 cm, thickness 2.5 cm).  Each tube was arranged in a grid and separated by 4 cm. Each 
tube contained 1.7 mL of 18F-FDG (0.2 µCi/mL). 
 
The tubes were scanned using a clinical thoracic protocol (Thorax C-A-P + C).   
The helical CT attenuation correction scan used a 1 mm slice thickness, an effective 
current of 80 mA, and 130 kVp.  Each PET scan was a 5 minute acquisition time with 
one bed position. The image reconstruction used the default OSEM 4i8s and FORE 
sinogram rebinning.  Two reconstructed images with different matrix sizes (128 x 128 
 34
and 512 x 512) were derived from the same data set.  The maximum activity 
concentrations of the objects were recorded from regions of interest drawn over all slices 
of each object.  We used the maximum value (instead of average) as used in the PET/CT 
exam in the clinical setting. 
3.2.3 Results and Discussion 
Maximum activity concentration of each source in three planes is shown in Figure 
3-5. For the X-Z and the Y-Z planes, the two outermost rows of tubes were not 
completely visualized because they were located outside of the 15 cm axial FOV.  
Consequently, maximum activity concentration values from these rows were not 
measured.  The average maximum activity concentrations with standard deviations are 
given in Table 3-2.  In Figure 3-5, the maximum activity concentration is plotted against 
the coordinates of the different planes and displayed as a continuous surface. Neither 
plane showed symmetry about the central X, Y, or Z axis (Figure 3-5).  We wished to 
acquire a blank scan to see if this gradient of the activity concentration was induced by 
background radiation such as from the shielded cylindrical 68Ge source in the 
examination room.  However, we could not obtain a blank scan because of the clinical 
scanning software would not allow image acquisition with no activity in the FOV. If the 
room’s background is substantial, background subtraction from acquired data should be 
used. In the future, one could scan a cylindrical 68Ge source and examine the activity 
concentration profiles to see if this variation is introduced by the routine normalization 
processes.  As in indirect check of room background, we surveyed the PET examination 
room with a survey meter (Biodex, Shirley, NY); the survey showed less than 100 cpm in 
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the PET’s FOV.  Thus, we expect that the background due to the 68Ge source in the room 
is probably negligible.   
Variations along the Z axis are less pronounced than along the X-axis and Y-axis 
(Figure 3-5 A and Figure 3-5 B).  In all planes, the 512 x 512 matrix produced less 
variation than the 128 x 128 matrix reconstructions; however the pattern of variation did 
not seem to be preserved.  Variation in the plane is reduced by the larger matrix size for 
the reconstruction algorithm.  PET field of view is fixed.  Increasing in matrix reduces 
the size of each pixel (128 x 128 matrix 5.15 mm; 512 x 512 matrix 1.29 mm).  The 
sonogram matrix size is fixed by manufacturer.  When the sonogram is converted into 
128 x 128 matrix size in transaxial slices, it loses some information; the lower matrix grid 
is too large relative to the size of the object. 
There is an optimal number of iterations to obtain the best image.  Too many 
iterations can lead to noise amplification with deterioration in image quality [24]. We did 
not examine the effect of iteration number within the scope of this thesis.  
One potential source of variation is the FORE rebinning process.   
 
Table 3-2:  Acquisition and reconstruction parameters of CTI-Siemens Reveal-HD.   
 Matrix size Average maximum activity 
concentration (Bq/mL) 
128 x 128 2766±438 X-Z plane 
512 x 512 2356±31 
128 x 128 2919±362 Y-Z plane 
512 x 512 2524±103 
128 x 128 3526±647 X-Y plane 






























































































































































































































































































































































































Figure 3-5:  Maximum activity concentration in three independent planes (A: X-Z, B:Y-Z, 
C: X-Y). The maximum activity concentration of each object is plotted according to its 
coordinate in the planes. Both 128x128 and 512x512 matrixes were investigated.   The 
curves in the 1-D plots represent the maximum concentration averaged in the orthogonal 
direction to the plot axis. Error bars represent standard deviation of the averaged values. 
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Sources placed in X-Y plane showed higher variation in activity concentration 
compared to ones in X-Z and Y-Z plane.  The reason of this is probably attributed to the 
geometrical shape of the object.  The X-Y plane produces the smallest transverse cross-
section of the object among three planes because of the geometry of the micro-centrifuge 
tubes.  The partial volume effect that is discussed in Chapter 5 induces more errors in 
activity concentration recovery in small objects.  Imaging of spherical objects rather than 
cylindrical tubes might be one way to minimize this effect; however such objects were 
not available at the time of the experiments.   
  Although we demonstrated better activity concentration recovery with 
OSEM4i8s in 512 x 512 matrix, in the clinical setting, a 128 x 128 matrix size is widely 
used.  For 128 x 128 matrix, it took 142 second to reconstruct images and for 512 x 512 
matrix, it took 1251 sec. Our scanning was only for one PET bed.  In a whole body PET 
scan for an adult patient, six PET bed positions are typical.   If the smaller matrix size is 
the major factor inducing error in the uniformity across the FOV, then computation time 
would be a part of the reason why our clinical mode is set to the lowest matrix size.  If 
the errors can be reduced by increasing matrix size, advancement of technology in 
minimizing computation time should allow us to use higher matrix size in reconstruction. 
We recommend using higher matrix size if we use PET data for quantitative purpose.   
Another consideration that we should note is that we acquired images in air.  To simulate 
clinical situations, one should image the tubes in a cylindrical phantom filled with 
physiological background 18F-FDG activity concentration. If we still see this non-
uniformity for discrete sources under this setting, then calibrations for discrete source 
objects may be necessary, instead of or after the manufacturer’s suggested normalization 
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process.   However, the normalization processes are done daily by manufacturer-created 
routine QA software and we did not have access to data to understand what exactly this 
software is doing for normalization.  To conclude whether another discrete source 
normalization process will improve accuracy of quantitation of the PET/CT scanner or 






Contrast Agents and PET/CT Data 
 
4.1 CT Numbers or Hounsfield Units (HU) 
CT numbers are quantitative.  CT numbers are used to identify the composition of 
a structure or lesion such as lung or bone.  After CT reconstruction, CT number 








×=                                         (14) 
CT numbers are called “Hounsfield units” (HU).  The CT images typically possess 12 
bits of values ranging from -1000 to +3095   
(air:  -1000, soft tissue: between -300 and -100, water: 0, dense bone: +3,000). 
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The benefits from the administration of contrast agents are significant especially 
in abdomen, pelvis, and head and neck studies.  Oral contrast agents are widely 
administered in most CT imaging because they help radiologists distinguish the 
gastrointestinal tract mucosal surface from other tissue in CT images.  Intra-venous (IV) 
contrast agents are also widely administered for CT for more accurate identification of 
vascular structures. Enhancement helps classification of lesions and also helps 
delineation of pathological lesions from normal structures such as muscles and vascular 
structures. Typical contrast agents are organic iodine (e.g., MD-Gastroview™ for oral 
contrast and Ominpaque™ for IV contrast) and barium sulfate (oral and barium enema).  
These agents are high atomic number materials; because of higher probability in 
photoelectric absorption, they enhance x-ray attenuation and hence contrast in image 
studies. 
PET/CT studies are not an exception for use of contrast materials.  PET/CT 
obtains ACF’s from the CT scan.  The method to obtain ACF’s in PET image requires a 
step to convert attenuation coefficients at energies of 30 – 140 keV into 511 keV values 
(Figure 4-1).  The algorithm used in the CTI-Siemens PET/CT has a threshold at 300 HU 
for converting either soft tissue or bone density.  Therefore, high CT numbers caused by 
contrast materials are interpreted as bone and can be scaled into a wrong ACF at 511 keV.  
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Theoretically, these overcorrected values could possibly lead to false representations of 
the PET images [35, 36].   
The majority of patients undergoing PET/CT are oncological patients and it is not 
infrequent for a patient to have a fluoroscopic study, receiving contrast agent for 
screening for gastro-intestinal (GI) malignancies, prior to the PET/CT scanning. 
Sometimes residual contrast agents in the GI tract are recognized after a topogram 
(patient-positioning) scan during PET/CT studies. Fluoroscopic contrast causes 
significant problems because a higher density of barium sulfate is used for these GI 
radiographs.  
In PET, the standard uptake value (SUV) is widely used to quantitatively 
distinguish a malignant lesion from a benign lesion.  The artifacts due to wrong HU 
scaling by contrast agents possibly may mislead physicians’ interpretations of the 
PET/CT image.  To investigate the effect of contrast material on SUV, first we tested HU 
for different dilutions of commonly used contrast materials.  Second, we investigated its 
effects on recovered activity concentration.   
Air-water mix Water-bone mix Cortical
-1,000
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Figure 4-1:  Plot of µ511/ µ70 as a function of HU. Scaling factors for soft tissue (water) 
and bone are indicated by horizontal lines [1]. 
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4.2.2 Materials and Methods 
Three types of commercial contrast agents were investigated. They are barium 
sulfate, oral iodine contrast, and IV iodine contrast. 
Barium sulfate: Berry smoothie Readi-Cat 2™. Barium sulfate suspension 2.1% w/v (EZ-
EM Inc. Westbuny, NY).   
Oral iodine contrast: MD-Gastoview™. 367 mg/mL organically bound iodine. Diatrizoate 
Megalumine and diatrizoate sodium solution (Mallinkrodt Inc. St.Louis, MO) 
IV iodine contrast: Ominpaque 300™ Injection.  647.1 mg/mL inhexol solution; 300 
mg/mL organically bound iodine (Amersham Health Inc. Princeton, NJ) 
• Experiment 1 
The following contrast materials were prepared in a series of dilutions in water as 
follows:  0, 1, 2, 4, 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100% (v/v) (100% means no 
dilution).  Ten milliliters of prepared contrast agents were placed into polyethylene 
centrifuge tubes (1.5 cm inner diameter, 12 cm tall, and 15 mL capacity) and were 
arranged in a Styrofoam rack as shown in Figure 4-2.  The rack was centered in the FOV 
of the PET/CT scanner using lasers.  For each contrast material, to minimize the effect of 
the location in the FOV, two scans were acquired: after the first scan, the rack was rotated 
180 degrees and the second scan was obtained.  CT images were obtained with the CTI-
Siemens PET/CT scanners using the scanning parameter described in Chapter 3.   
The images were analyzed using the scanner’s software.  For each tube, circular 
regions (37 pixels, 0.35 cm2 area) were drawn in three places, at the top, middle, and 
bottom of each object, and the mean CT value for each region was recorded.   
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• Experiment 2 
Gastroview™ and Omnipaque 300™ were prepared in a series of dilutions of 0, 1, 
4, 10, 20, 30, 40, 50, 60, 80, and 100% (v/v) as explained in Experiment 1.  
A 1.0 mL volume of diluted contrast material was pipetted into 1.5 mL polyethylene 
micro-centrifuge tubes (0.9 cm inner diameter), and arranged in a micro-centrifuge rack.  
The tubes were arranged in columns spaced at 2.4 cm, 4.0 cm, and 5.6 cm from center of 
the rack and FOV as illustrated in Figure 4-3.  
A stock solution of 18F-FDG was prepared at the concentration of 109.6 µCi/mL. A 10 
µL volume of 18F-FDG was pipetted into the 1 mL solution in each tube (1.1 µCi/mL).    
Different contrast concentrations were arranged in the Z-direction because we know that 
the variation of the measured activity concentration is less in this direction from the 
experiment in section 3.1.2.   
 PET images were acquired on the Reveal HD scanner using the default Thoracic 
protocol, except the slice thickness was set to 2 mm.  The image data were viewed with 
the PET/CT scanner software and the maximum pixel value of each object was recorded.  
For comparison, images were also acquired using a GE Discovery ST PET/CT 
scanner (The GE Discovery ST is owned by Mary Bird Perkins Cancer Center) in the 







60 70 80 90 100
20 30 40 50






Figure 4-2: Arrangement of 15 mL centrifuge tubes.  The tubes were separated 4 cm 
horizontally and 4.5 cm vertically.  After the first scan, the arrangement was rotated 180 
degree about the center of the FOV and a second scan was obtained. Numbers are 






























Figure 4-3:  Arrangement of the micro centrifuge tubes.  Numbers are dilution in % as 
described in Materials and Methods. Centers of the vertical columns of tubes are 2.4 cm, 
4.0 cm, and 5.6 cm from the FOV center.  Each row was separated by 1.3 cm.   
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4.2.3 Results and Discussions  
• Experiment 1 
Gastroview™ and Omnipaque 300™ demonstrated similar plots of CT values 
(Figure 4-4).  These contrast agents contain similar organic iodine concentrations. At 
3071 HU, the CT values were saturated.  This is due to computer memory of CT numbers 
allocated, 12 bits.  The typical clinical protocol uses 25 mL of Gastroview™ diluted into 
240 mL of water. This yields approximately 10% on our dilution scale.  The diluted 
Gastroview™  is administered to the patient orally about 15-30 minutes prior to an 
examination to allow the material to reach the pelvic bowel loop.  For 2.1% barium 
sulfate, the CT value was lower than either iodine contrast agent for all dilutions.  At 10% 
dilution for Gastroview™, the CT value was 822±22 HU.  This is well above 300 HU 
where a CT number’s segmentation algorithm has discontinuities, discussed in Chapter 
2.2.2.  The effect on the ACFs of barium sulfate, widely used in the clinical CT study, 
likely is negligible, because all concentrations below 70% have CT numbers less than 


































































































Figure 4-4:  CT numbers in HU vs. concentration of contrast agents.  As concentrations 
of Gastroview and Omnipaque increase, CT number saturates at 3,071 HU, which is near 
the maximum for 12 bits CT memory.  The 2.1% barium sulfate dilutions span a smaller 
range of CT numbers and did not saturated at high concentrations. 
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• Experiment 2 
The F-18 activity concentration as a function of contrast concentration is shown in 
Figure 4-5.  For CTI/Siemens scanner, the largest error in average maximum activity 
concentration was seen at the highest dilution (80%).  Activity concentration was 
overestimated 59% for Gastroview™ and 39% for Omnipaque 300™ at 80% dilution.  At 
10% dilution, the error was 19% and 7% respectively.  At 10% dilution for Gastroview™, 
the clinical dose given to patient, the error in recovery in activity concentration may not 
be negligible.  These data are consistent with our results described in Chapter 3: 
recovered activity concentrations are a function of position in the FOV.  There are 
published articles using phantoms regarding contrast materials and activity concentration 
recoveries [17]; however no article has mentioned this variation of the activity 
concentration in the FOV. For a phantom study, we think radioactive materials in the 
FOV need to be carefully arranged to account for this variation.  One problem that we did 
not consider at this point was distance between each row of micro-centrifuge tubes. Each 
row was only separated by 1.3 cm; we cannot rule out that the PET scanner resolution 
may cause the tube’s image to overlap, altering the apparent maximum intensities.  We 
investigate this issue in Chapter 5.   
 We also tested a different scanner (GE).  The Discovery ST is a BGO based 
system (6 mm x 6 mm BGO crystals) which is larger than CTI-Siemens BGO crystals (4 
mm x 4 mm) 
Errors were as follows.  Gastroview™:  26% for largest error at 60% dilution, 12% error 
for 10% dilution.  Omnipaque™: 13% for largest error at 60% dilution, 5% error for 10% 
dilution.  The GE system had less maximum error.   The reason why 60% not 80% 
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dilution produced maximum error is unknown.  We did not measure the variation of 
activity concentration across the FOV for this scanner.  The GE scanner uses septa to 
acquire 2D mode data, unlike the Reveal scanner.  With the different concentrations 
arranged in the axial direction of the gantry, it is possible that subtle differences in the 
position of objects in relation to the septa affect the potential sensitivity.  Further 
investigation of the GE scanner was viewed as an extension to the primary purpose of 
this thesis.  In the future one should investigate the effect of 2D vs. 3D acquisition modes 
on system response uniformity.  The GE scanner is capable of retracting its septa to 
acquire data in 3D mode, so it would be an ideal platform for further investigation. 
A recent clinical study reported that the PET artifact by an intravenous contrast  
material was limited to the thoracic veins containing undiluted contrast agent [36]. They 
also found that patients with artificially high uptake values have statistically smaller body 
surface area than patients with no artifacts. Another possible cause of artifacts is that 
bolus IV contrast passages are imaged in the CT scan but when the PET data are acquired 
subsequently, the high concentration of the contrast materials has redistributed 
throughout the body.  
Another group reported that high density barium oral contrast used for some GI 
studies can potentially overcorrect ACFs, but  the low density agent typically used for CT 
has negligible effects [37].   
One group has investigated changes in contrast agent density with location in the 
GI tract.   Their study used 3% gastrographin (equivalent to Gastroview) and 1.5% 
barium sulfate.  As the oral contrast agent goes down the GI tract, the density increased: 
gastrographin from 143 ± 37 HU in stomach to 243 ± 43 HU in ileum; barium from 
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171±45 HU in stomach to 263±24 HU in ileum.  They demonstrated overestimation of 
activity concentrations (for gastrographin 20%; barium 21%).  For 50% dilution of 
barium, a typical concentration used in colonography, the over-estimation of activity 
concentration was 580% [38]. 
 These studies indicated that if the administered volume of intravenous contrast 
material is corrected according to body surface area of the patient, the effect on ACFs is 
negligible.  Barium contrast materials for gastrointestinal radiography (such as barium 
enema) may adversely affect ACFs for PET imaging.   
Another study compared recovered activity concentrations in different organs for 
Ge-68 based and CT-based ACFs [39].   CT-corrected emission images showed slightly 
higher radioactivity concentration values for all malignant lesions and all normal organs 
except lung (mean 4.3% and maximum 15.2% higher).  This indicates that comparison of 
quantitative analysis between different ACF correction methods has to be careful; one 
must be careful comparing SUV values among different scanners.  
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Figure 4-5:  Measured activity concentration as a function of concentration of contrast 
agents.   Two different scanners are compared (A: CTI/Siemens Reveal and B: GE 
Discovery).  Activity concentrations for three individual distances from the center and 



























































































































































































































































Recovery of Radioactivity Concentrations 
of Small Spheres 
 
 
5.1 Object Size and Radioactivity Concentration 
5.1.1 Motivation 
• Quantitative Analysis in Oncology 
The beneficial use of the PET/CT scanner is already demonstrated in management 
of oncological patients in many studies. 18F-FDG PET has a major impact on the 
management of patients with small lung cell cancer; in 29% of patients both the stage and 
the management was influenced by the PET results.  Accurate quantitation of small 
lesions is especially important for diagnosis.   
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• Partial Volume Effect 
  In ideal quantitative PET, the image should represent the distribution of 
radioactive tracer concentration as a size-invariant function. Partial volume effect causes 
a small object, less than twice the spatial resolution of the imaging system, to have 
reduced signal amplitude [18, 23, 40].  This effect has been widely addressed in brain 
research where quantitative analysis of small areas of abnormal cortex within normal 
tissue is critical.  If object size affects accuracy of tracer activity concentration recovery, 
we need to know the limitation of the method in an oncological setting.  An inaccurate 
recovery of small lesions affects diagnosis and evaluation of the malignant lesions.  
Surprisingly, partial volume effects are not widely discussed in textbooks or review 
articles related to diagnosis of malignancy using PET/CT.  Little information was found 
in the literature about the influence of partial volume effect on maximum pixel value 
measurements, such as one uses in clinical settings to calculate SUV.  We tested several 
different sizes of spheres and sought to identify the critical object size that results in 
significant error in recovered activity concentration for diagnosis in the oncological 
setting. 
5.1.2 Materials and Methods  
A 0.4 µCi/mL (14800 Bq/mL) activity concentration of 18F-FDG was prepared in 
a volume of 50 mL water.  Four different diameters of plastic spheres (10 mm, 14 mm, 18 
mm, and 23 mm inner diameters) were arranged on a 6 cm radius circle on the scanner’s 
X-Z plane.  The objects’ centers were evenly spaced.  For each diameter, three identical 
sizes of spheres, except for the largest 23 mm sphere, were arranged alternately and two 
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scans were obtained, by rotating 60 degrees around the center for each scan to minimize 
the effect of the location in the FOV which we discussed in Chapter 3.  The routine 
thoracic protocol explained in the previous chapter was selected for scanning.  The CT 
was set to 80 mA, 130 kV, and 1.0 mm slice thickness.  The PET data was acquired in 
one PET bed for 5 minutes.  The OSEM 4i8s with 128 x 128 matrix was used to 
reconstruct images.  The maximum activity concentration (Bq/mL) of the objects in each 
reconstructed image was recorded.  The average value was calculated from each size and 
the two scans. 
5.1.3 Results and Discussions 
The results indicate that the activity concentration error is larger, when the object 
diameter is smaller.  The largest error of activity concentration was observed in the 10 
mm sphere, which gave 46% of activity concentration of the largest sphere, as shown in 
Figure 5-1.  The 1.4 cm sphere showed 85% of the recovered activity of the 2.3 cm 
sphere and the 1.8 cm sphere gave 97%.  The 2.3 cm sphere gave an activity 
concentration of 4387 Bq/mL, compared to the expected value of 14800 Bq/mL.  This 
error increases drastically for lesions less than 1.5 cm.  The FWHM of the PET/CT 
scanner is approximately 7 mm.  As previous publications indicated, objects less than 
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Figure 5-1:  Maximum activity concentration as a function of sphere diameter.  The 1.0 
cm sphere recovered an activity only 46% of that recovered by the 2.3 cm sphere.  Sphere 
less than ~1.4 cm diameter exhibit more error than larger spheres. The error bars 
represent standard deviation of the average of the two scans and the three spheres of each 
size.   
 
According to the results, correction factors are required according to the object’s 
size.  In PET in the experimental setting, the sizes of the objects are known prior to 
scanning.  In clinical settings, we do not know the size of the lesion in advance.  However, 
to recover a correct activity concentration, we need an estimation of the object size.   
One approach is to use another imaging method, such as MRI or CT, to estimate object 
size.  Unfortunately, small lesions may not be visible on either of these imaging methods 
in real practice. Some lesions visible on PET are not visible for other imaging methods.  
In that case, there is no way to recover the size of the object other than from PET data 
itself.   
In an ideal situation, if the object has uniform radioactivity uptake in the lesion 
and if we know the point spread function of the PET image, by deconvolving the PSF 
from the image, we can theoretically recover an activity distribution map in the body. 
If the lesion is visible on CT, then PET/CT has an advantage: the object size is 
available in CT data sets.  Problems arise however.  (1) Even normal tissue in organs 
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does not guarantee uniform activity distribution across patients, because there are 
variations among individuals.  (2) Malignant lesion’s uptake is not uniform for 18F-FDG 
as we discussed in Chapter 1.  Uptake reflects hypoxic cells and there are variations in 
uptake even within a single malignant lesion.     
A literature search revealed an article discussing recovery of sphere objects [41].   
Accurate quantitation of small lesions requires correction for the partial volume effects.  
This correction factor is called recovery coefficient (RC), and depends on the lesion size, 
the object-to-background ratio, and the physical properties of the object.  Several 
approaches have been proposed to correct for partial volume effects [18, 40-42].   




In the last section, we investigated the recovery size for a single object.  Next, we 
investigated distances between objects for recovery of activity concentrations.  
Malignant lesions such as lymph node metastasis are sometimes located next to each 
other. Suppose we have recovered the correct activity concentration according to the 
object sizes, we still do not know if the distance between objects affects the recovery of 
activity concentrations.   
If we place a true point source, in an ideal imaging system, the activity 
concentration in the image is registered as a delta function or a peak only in one pixel. 
However, in a real imaging system, there is a finite spread of the values.  An observed 
image is a point spread function convolved with the distribution of the activity source.  
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One can imagine as two objects get close to each other, the activity concentration 
distributions overlap and alter the recovered values.   
We chose spheres because lesions that we are interested in such as lymph nodes 
are generally spherical.  We have tested two different sizes of three identical spheres 
separated in five different positions. We have also compared OSEM reconstruction to 
FBP reconstruction.  FBP is important not only because it has minimal computational 
time compared to iterative algorithms, but also it is a linear analytical algorithm, ideally 
providing better control of the spatial resolution and noise reduction, a control necessary 
for quantitative data analysis [23].  We tested the FBP algorithm in different matrix sizes, 
and compared to OSEM to see if FBP provides more accurate activity concentration 
recoveries. 
5.2.2 Materials and Methods 
• Experiment 1  
Three identical sizes of plastic spheres (10 mm and 18 mm inner diameter; 1 mm 
wall thickness) were aligned on the X axis at the center of the FOV.  Outer walls of the 
three spheres were separated by 0 mm, 5 mm, 10 mm, 15 mm, and 20 mm (Figure 5-2) 
and data were acquired using the CTI-Siemens PET/CT scanner as described in Chapter 3.  
The activity concentration was 0.2 µCi/mL (7400 Bq/mL) and the scans used the Thorax 
C-A-P + C protocol.  The default reconstruction algorithm (OSEM 4i8s, FORE, 128 x 
128 matrix) was used to reconstruct images.   Attenuation uncorrected image files 
formatted in DICOM was analyzed using IDL 5.6 student edition (Research System Inc., 
Boulder, CO).  For each transaxial slice, each column was searched for the maximum 
pixel number and multiplied by the rescaling slope found in the DICOM file to create 
 57
maximum activity concentration profiles.  The slices with the maximum activity 
concentration were identified.  The maximum activity concentration was analyzed as a 
function of position in the image profiles. 
• Experiment 2 
Three spheres were positioned at the center of FOV along the X-axis.  We only 
tested the 10 mm sphere because we already know that the 18 mm sphere gives relatively 
accurate recovery of activity concentration from Experiment 2 of Chapter 5.1.  Three 
identical 10 mm plastic spheres were aligned on the X axis at the center of FOV.  The 
outer walls of the spheres were separated by 0 mm and images were acquired with the 
CTI-Siemens PET/CT scanner as described in Chapter 3.  The activity concentration was 
0.2 µCi/mL (7400 Bq/mL).  The same raw data were reconstructed three different ways 
into images.  The methods were (a) OSEM 4i8s, FORE, 128 x 128 matrix; (b) FBP with 
Gaussian filter with 3mm FWHM, 128 x 128matrix; (c) FBP with Gaussian filter with 
3mm FWHM, 512 x 512 matrix. Attenuation uncorrected image files formatted in 
DICOM were analyzed using IDL 5.6 student edition (Research System Inc., Boulder, 
CO).  For each transaxial slice, each column was searched for the maximum pixel 
number to created image profiles.  All trans-axial slices were examined and the slice that 
gave the maximum pixel numbers was selected and multiplied by the rescaling slope 
found in the DICOM file to calculate maximum activity concentration.  Activity 
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Figure 5-2:  Arrangement of three identical hollow spheres.  The separations of the 
objects were measure in separation of outer walls.  The center sphere was located at the 
center of FOV.  The three balls were arranged in tandem along the X-axis.   
 
5.2.3 Results and Discussion 
• Experiment 1 
The results are shown in Figure 5-3.  Variations in maximum activity 
concentrations were greater in 10 mm spheres than in 18mm spheres.  This is probably 
due to the partial volume effect that we discussed previously. For a small object, only a 
small number of pixels compose its image, possibly introducing significant errors in 
recovery of activity concentrations.  The locations of small objects relative to the pixel 
grid might have a large effect. Some of the variation may also be due to the location-
dependent variation in uniformity described in Chapter 3.  All recovered activities were 
less that the values prepared (7400 Bq/mL).  Errors are possibly attributed to 
normalization process of the PET/CT scanner or dose calibration error using well counter.  
We did not investigate the cause of the errors at the time of experiment.   
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Overlaps of the images of the spheres are not as great as we expected; the amount 
of overlap is indicated by the profiles not reaching a value of zero.  At 10 mm separation, 
the objects do not overlap. This is consistent with the PET resolution of 7 mm FWHM.  
• Experiment 2 
Figure 5-4 shows the results for the three different reconstruction methods.  Our 
results indicate that increasing matrix size for FBP improves the recovery of maximum 
activity concentrations for the three spheres.  Increased matrix size has a smoothing effect 
on objects (Figure 5-4).  This is consistent with the results in Chapter 3 testing different 
matrix size with OSEM.  An increase in matrix size improved the recovery of activity 
concentrations.  We used the same raw data to reconstruct images using the three 
different methods. Calibrated activity concentration was 0.2 µCi/mL (7400 Bq/mL).   The 
maximum activity concentrations were highest in OSEM 128 x 128 among all three 
algorithms; however it still has lower activity concentration than calibrated values.  This 
indicates that recovered activity concentrations were not quite accurate for any method.  
Among the three reconstruction algorithms, 512 x 512 FBP gave less variation in 
maximum activity concentrations. 128 x 128 FBP gave the smallest activity concentration 
values. The discrepancies observed in all experiments between calibrated and recovered 
activity concentrations could be due to calibration errors in the well counter when 
measuring a small activity source. Likewise, scaling errors from counts per pixel to 































































































































Figure 5-3: Profiles of maximum activity concentrations of three spheres arranged in 
tandem. 10 mm and 18 mm diameter spheres were tested. Outer walls of spheres were 
separated 0, 5, 10, 15, and 20 mm.   Maximum pixel values were searched in Y-direction 













































































Figure 5-4:  Maximum activity concentration recovery for three spheres arranged in 
tandem are plotted as a function of position in X-direction. Three different image 
reconstructions were tested on the same raw data. A: OSEM 4i8s 128 x 128matrix, B: 
FBP 128 x 128 matrix, and C: FBP 512 x 512 matrix.  Outer walls of the spheres are 








In Chapter 3, we demonstrated that the currently available clinical PET/CT 
scanner does not guarantee accurate recoveries of activity concentrations with clinical 
scanning modes. The normalization process of the PET scanner using a continuous 
volume source does not lead to an accurate normalization of discrete small sources in the 
FOV.  Also the image reconstruction parameters should be optimized by further 
investigations.   
In Chapter 4, we tested one of the possible factors, contrast agents, that might 
affect quantitation of the PET/CT data. The iodine-based oral and intravenous contrast 
agents we tested seem to be in the range where the effects on attenuation correction 
factors may be negligible, except for some particular conditions discussed in that Chapter.   
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In Chapter 5, we demonstrated that the size of the objects affects activity 
concentrations; errors are not negligible for small objects less than twice the FWHM of 
the PET scanner. To use PET/CT as a quantitative method, an algorithm that corrects for 
object size variation is probably necessary.  However, obtaining an accurate estimate of 
object size can be difficult in clinical situations.  Our multiple lesion model using three 
spheres demonstrated the major issue is their sizes rather than separation between objects, 
probably because of partial volume effects.  Increasing the matrix size of the 
reconstructed image improved the PET/CT scanner’s quantitative accuracy.  Immediate 
possible improvement of clinical PET/CT scanner is to increase matrix size of 
reconstruction for quantitaion purpose.  .  Another solution is to improve PET scanners’ 
resolution, thereby reducing partial volume effects 
A question thus arises:  Suppose we could overcome all technical difficulties of 
recovering the activity concentration.  We are still dealing with many factors involved in 
calculation of SUV’s, such as variation in metabolism of 18F-FDG among patients and 
variation in time elapsed between injections and scanning (although the scanners decay-
correct the image data, count statistics will change).  Consequently, is SUV the best 
choice?    
It seems to be more reasonable to use an average uptake value of the organ which 
is unique to an individual patient and an individual scanner to distinguish malignant 





mLBqLesionRatio =                                                  (15) 
Lesion : Activity concentration of the region of interest  
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OrganAverage : Average activity concentration of all pixels in the 
specified organ 
 
Delineation of organs and ROIs is labor-intensive.  The development of automated 
segmentation algorithms would be helpful for this task. 
 A similar approach has been used in radiology.  A CT scan data set has gray scale 
values in HU.  For diagnosing different lesions in different organs, radiologists will 
typically look at three sets of images:  bone window, soft tissue window, and lung 
window.  The CT value is a representation of a physical property (attenuation 
coefficients) unique to each tissue type. These windows can be optimized manually by 
the radiologist; the optimal bone window may be different in health young individuals as 
opposed to an older individual with osteoporosis.  However, each window does not vary 
greatly among individuals. 
 In 18F-FDG PET, an analogous window approach is not possible.  This is due to 
18F-FDG uptake reflecting both normal tissue and tumor physiology.  The distribution of 
activity concentration varies from patient to patient.  Given the activity concentrations of 
individual pixels, one cannot conclude if it is normal tissue or a malignant lesion.  
However, SUV value is essentially taking this approach for every patient; only the 
absolute magnitude is considered, rather than the magnitude in relation to surrounding 
organs.  SUV certainly works if we have a highly-specific radioactive tracer, which 
exhibits no uptake in normal tissue.  However 18F-FDG PET with current instrumental 
limitations of PET scanners may not provide useful SUV values. 
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Well experienced nuclear medicine physicians do threholding manually to 
optimize display windows and they should carefully examine both attenuation-corrected 
and uncorrected images to visualize the lesions (Figure 6-1).  However, this requires a lot 
of experience; a majority of physicians may not be aware of the importance of 
thresholding necessary for accurate diagnosis and may overlook some lesions.  With the 
current PET/CT, with CT images’ anatomical information, one can delineate organs and 
ROIs.  CT-based delineation may help with the calculation of equation (12) and may also 
help to select a proper PET window.   Then by comparing the activity concentration in 
ROI with the background concentration in particular organs, we can establish more 
accurate information about the lesions.   
 
Our conclusion is:  Although 18F-FDG based PET/CT scanners have great 
advantages in radiation therapy, particularly for detecting radiotherapy-resistant hypoxic 
lesions, the currently available scanners are not completely satisfactory for strict 
quantitative analysis.  Developing methods to calculate recovery coefficients for discrete 
sources according to size and uptake is essential to assure the quantitative quality of 
PET/CT in oncology settings. The development of parameters other than SUV may 
overcome SUV’s inherent limitations reflecting the patient physiology and the scanner 
characteristics.  We suggest that an individual organ-based PET activity concentration 





























Figure 6-1:  An example of the importance in optimizing display windows of both 
attenuation-corrected and uncorrected image sets to visualize a lesion.  A-C: attenuation 
uncorrected image, D-F: attenuation corrected image.  A lesion is visible on A, but not on 
D.  B and E are transaxial fused PET/CT images.  The lesion is easily detected on B.  
Only optimal windowing will allow physicians to visualize the lesion on E.  C and F are 
transaxial CT images.  The lesion is not easy to evaluate from CT images only (Courtesy 
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